Partner Michael G. Bailey was quoted in an article that appeared in The Bond Buyer on August 20, 2012 titled “IRS Says $9.95M of IDBs May Be Taxable.” Bailey provided comment on a provision in the Internal Revenue Code that sets a tax law limit of $20 million on capital expenditures made in the county for tax-exempt small-issue IDBs. He indicated that it is difficult for borrowers to monitor compliance because it includes capital expenditures outside of the project. Bailey also stated that the IRS has been aware of this issue since 1993 and that provision was cited as one of the three most likely areas of noncompliance for muni issuers and borrowers.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”